JANSSEN-CILAG A/S: Financial statements 2025
CVR: 19248615
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
JANSSEN-CILAG A/S (CVR 19248615) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. That is a decrease of 5.2% compared with the year before. The profit margin was 3%. Equity in the 2025 report amounted to DKK 216,425,000. The solvency ratio was 31.6%. The company had 112 employees in the financial year.
- Revenue
- DKK 1,442,304,000
- Gross Profit
- DKK 219,282,000
- Profit/Loss
- DKK 43,183,000
- Equity
- DKK 216,425,000
- Total Assets
- DKK 684,146,000
- Employees
- 112
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.4B | 219.3M | 43.2M | 216.4M | 112 |
| 2024 | 1.5B | 240.9M | 64.5M | 173.2M | 116 |
| 2023 | 1.4B | 290.4M | 45M | 158.8M | 127 |
| 2022 | 1.5B | 309.4M | 59.8M | 163.7M | 135 |
| 2021 | 1.3B | 286.1M | 60.6M | 135M | 142 |
Official annual report
How creditworthy is JANSSEN-CILAG A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
JANSSEN-CILAG A/S has won the tender "Udbud af hofte-, knæ- og skulderalloplastikker og knoglecement" issued by Region Hovedstaden worth 1,120,757,760 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2026 1.1178.a" issued by Amgros I/S worth 5,780,000 DKK.
JANSSEN-CILAG A/S has won the tender "Udbud af kardiologiske produkter til ablationsbehandling" issued by Region Syddanmark worth 4,400 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2026 1.617.b" issued by Amgros I/S worth 43,827,250 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2026 1.166.a" issued by Amgros I/S worth 804,000,000 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2025 1.352.a" issued by Amgros I/S worth 157,080,000 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2026 1.810.a" issued by Amgros I/S worth 137,104,621 DKK.
As of August 11, 2025, Mikkel Dohm Johansen has left the board of directors of JANSSEN-CILAG A/S.
JANSSEN-CILAG A/S has won the tender "Genudbud af sutur" issued by Region Hovedstaden worth 50,641,955 DKK.
JANSSEN-CILAG A/S has won the tender "Amgros 2026 1.981.a" issued by Amgros I/S worth 53,000,000 DKK.
About JANSSEN-CILAG A/S
JANSSEN-CILAG A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 1969. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JANSSENPHARMA A/S. The management consists of Mario Klesse. The board consists of Philipp Christian Hellweg (chair), Liana Akhmetzhanova, Mario Klesse and Nevret Mahmudovski. The company is owned by Janssen Cilag AB. The company has 116 employees (2026). In 2025, the company reported revenue of DKK 1,442,304,000 and a net result of DKK 43,183,000 compared with DKK 64,466,000 the year before. Equity in the 2025 report amounted to DKK 216,425,000.